Abstract Body

Epithelial cells (EC) are the first to capture HIV/SIV at portal sites of entry and transmit the virus to subjacent immune cells via transcytosis. The interplay between EC and Th17 cells is critical for the maintenance of immune homeostasis at mucosal level as well as viral dissemination. Th17 cells produce cytokines that act on EC to promote the production of CCL20/MIP-3α, an antimicrobial peptide and chemoattractant for CCR6+ Th17 cells. CCL20 was reported to limit HIV replication in T-cells by inducing APOBEC3G expression. Other studies demonstrated that CCL20 contributes to the establishment of HIV latency in CD4+ T-cells and promotes dissemination from the portal sites of entry. Herein, we investigated the impact of HIV-1 on the interplay between EC and Th17 cells and studied EC-T cell trans infection in an environment rich in CCL20.

Intestinal EC line HT-29 was stimulated with recombinant human TNF-α and/or IL-17A in the presence or absence of the wild type R5 HIV strains NL4.3BaL and transmitted founder THRO. Memory CD4+ T-cells were isolated by magnetic beads from uninfected individuals and stimulated with CD3/CD28 Abs. EC-T cell trans infection was studied in co-culture experiments between HIV-exposed EC and activated T-cells. CCL20, CXCL8/IL-8, and HIV-p24 levels were quantified in cell culture supernatants by ELISA. The expression of IL-17 receptor A and C (IL-17RA/RC) on EC and the intracellular expression of HIV-p24 in T-cells were quantified by FACS.

IL-17A acted only in synergy with TNF-α to promote CCL20 but not CXCL8 production in EC. This synergy coincided with the TNF-α-mediated up-regulation of IL-17RA expression on EC. HIV exposure further increased CCL20 production by EC in response to IL-17A and TNF-α. Although CCL20 inhibited HIV replication in T-cells cultured alone, HIV trans infection of T-cells co-cultured with HIV-loaded EC occurred more robustly in the presence of high levels of CCL20 levels produced by EC in response to IL-17A and TNF-α.

We demonstrate that IL-17A acts in synergy with TNF-α to promote CCL20 production in intestinal EC, HIV further amplifies this synergy, and HIV transmission from EC to T-cells is proportional to the magnitude of CCL20 production by EC. Together these results reveal that HIV-1 exploits the interplay between EC and Th17 cells for its own replicative advantage and that CCL20 plays an important role in HIV dissemination from the portal sites of entry.